BON NATURAL LIFE LTD-A (BON) Stock Fundamental Analysis
USA - NASDAQ:BON - KYG144922047 - Common Stock
2 USD
+0.17 (+9.29%)
We assign a fundamental rating of 3 out of 10 to BON. BON was compared to 82 industry peers in the Chemicals industry. BON has an average financial health and profitability rating. BON is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
BON had positive earnings in the past year.
In the past year BON has reported a negative cash flow from operations.
In the past 5 years BON has always been profitable.
In multiple years BON reported negative operating cash flow during the last 5 years.
1.2 Ratios
BON has a Return On Assets (0.81%) which is comparable to the rest of the industry.
The Return On Equity of BON (1.08%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.23%, BON is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
BON had an Average Return On Invested Capital over the past 3 years of 8.52%. This is above the industry average of 6.14%.
The last Return On Invested Capital (2.23%) for BON is well below the 3 year average (8.52%), which needs to be investigated, but indicates that BON had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.81% | ||
| ROE | 1.08% | ||
| ROIC | 2.23% |
ROA(3y)9.09%
ROA(5y)10.38%
ROE(3y)11.65%
ROE(5y)16.28%
ROIC(3y)8.52%
ROIC(5y)10.57%
1.3 Margins
BON has a Profit Margin (2.67%) which is in line with its industry peers.
In the last couple of years the Profit Margin of BON has declined.
The Operating Margin of BON (9.59%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BON has declined.
The Gross Margin of BON (27.99%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BON has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.59% | ||
| PM (TTM) | 2.67% | ||
| GM | 27.99% |
OM growth 3Y-28.15%
OM growth 5Y-16.51%
PM growth 3Y-54.74%
PM growth 5Y-36.12%
GM growth 3Y2.25%
GM growth 5Y-1.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BON is creating some value.
The number of shares outstanding for BON has been increased compared to 1 year ago.
Compared to 5 years ago, BON has more shares outstanding
BON has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.49, we must say that BON is in the distress zone and has some risk of bankruptcy.
BON has a worse Altman-Z score (1.49) than 69.51% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that BON is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.15, BON belongs to the best of the industry, outperforming 84.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.49 |
ROIC/WACC0.32
WACC6.96%
2.3 Liquidity
A Current Ratio of 2.44 indicates that BON has no problem at all paying its short term obligations.
The Current ratio of BON (2.44) is better than 68.29% of its industry peers.
A Quick Ratio of 2.29 indicates that BON has no problem at all paying its short term obligations.
BON's Quick ratio of 2.29 is amongst the best of the industry. BON outperforms 85.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.29 |
3. Growth
3.1 Past
The earnings per share for BON have decreased strongly by -94.80% in the last year.
Measured over the past years, BON shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -44.75% on average per year.
BON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.44%.
The Revenue has been growing slightly by 7.78% on average over the past years.
EPS 1Y (TTM)-94.8%
EPS 3Y-71.08%
EPS 5Y-44.75%
EPS Q2Q%346.26%
Revenue 1Y (TTM)-15.44%
Revenue growth 3Y-2.21%
Revenue growth 5Y7.78%
Sales Q2Q%-21.93%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
BON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.08% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year77.63%
Revenue Next 2Y45.28%
Revenue Next 3Y34.64%
Revenue Next 5Y24.08%
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 0.59, which indicates a rather cheap valuation of BON.
Based on the Price/Earnings ratio, BON is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.06. BON is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.59 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -0.11 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
BON does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BON (11/10/2025, 4:30:01 PM)
2
+0.17 (+9.29%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap8.10M
Revenue(TTM)21.61M
Net Income(TTM)577.90K
Analysts0
Price TargetN/A
Short Float %1.14%
Short Ratio0.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.59 | ||
| Fwd PE | N/A | ||
| P/S | 0.37 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.15 | ||
| P/tB | 0.15 | ||
| EV/EBITDA | -0.11 |
EPS(TTM)3.4
EY170%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)-2.5
OCFYN/A
SpS5.34
BVpS13.22
TBVpS13.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.81% | ||
| ROE | 1.08% | ||
| ROCE | 3.83% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.61% | ||
| ROICexgc | 2.64% | ||
| OM | 9.59% | ||
| PM (TTM) | 2.67% | ||
| GM | 27.99% | ||
| FCFM | N/A |
ROA(3y)9.09%
ROA(5y)10.38%
ROE(3y)11.65%
ROE(5y)16.28%
ROIC(3y)8.52%
ROIC(5y)10.57%
ROICexc(3y)8.65%
ROICexc(5y)11.01%
ROICexgc(3y)8.8%
ROICexgc(5y)11.18%
ROCE(3y)13.84%
ROCE(5y)17.18%
ROICexgc growth 3Y-44.37%
ROICexgc growth 5Y-33.89%
ROICexc growth 3Y-44.35%
ROICexc growth 5Y-33.92%
OM growth 3Y-28.15%
OM growth 5Y-16.51%
PM growth 3Y-54.74%
PM growth 5Y-36.12%
GM growth 3Y2.25%
GM growth 5Y-1.53%
F-Score4
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 0.62% | ||
| Cap/Sales | 0.03% | ||
| Interest Coverage | 6.4 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.29 | ||
| Altman-Z | 1.49 |
F-Score4
WACC6.96%
ROIC/WACC0.32
Cap/Depr(3y)764.29%
Cap/Depr(5y)1250.29%
Cap/Sales(3y)6.63%
Cap/Sales(5y)12.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.8%
EPS 3Y-71.08%
EPS 5Y-44.75%
EPS Q2Q%346.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.44%
Revenue growth 3Y-2.21%
Revenue growth 5Y7.78%
Sales Q2Q%-21.93%
Revenue Next Year77.63%
Revenue Next 2Y45.28%
Revenue Next 3Y34.64%
Revenue Next 5Y24.08%
EBIT growth 1Y-31.3%
EBIT growth 3Y-29.74%
EBIT growth 5Y-10.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-198.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-353.53%
OCF growth 3YN/A
OCF growth 5YN/A
BON NATURAL LIFE LTD-A / BON FAQ
Can you provide the ChartMill fundamental rating for BON NATURAL LIFE LTD-A?
ChartMill assigns a fundamental rating of 3 / 10 to BON.
What is the valuation status of BON NATURAL LIFE LTD-A (BON) stock?
ChartMill assigns a valuation rating of 2 / 10 to BON NATURAL LIFE LTD-A (BON). This can be considered as Overvalued.
How profitable is BON NATURAL LIFE LTD-A (BON) stock?
BON NATURAL LIFE LTD-A (BON) has a profitability rating of 4 / 10.
What is the valuation of BON NATURAL LIFE LTD-A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BON NATURAL LIFE LTD-A (BON) is 0.59 and the Price/Book (PB) ratio is 0.15.
Can you provide the financial health for BON stock?
The financial health rating of BON NATURAL LIFE LTD-A (BON) is 4 / 10.